Engineering

Secretion Study

The amplification of the T-cell activation response in our genetic circuit relies on secretion of target antigen ecto-domains into the extracellular space. Endogeneously, only some proteins are secreted from cells, while others operate inside of the cell where they are created. When engineering proteins that need to be secreted, it is neccesary to "tag" them via the addition of N-terminal peptides. These secretion tags are sequences of 15-20 amino acids that signal to the cell that the tagged protein needs to be sent outside of the cell.

In the genetic engineering space, these fused tags are known to affect total expression of the linked protein and downstream secretion efficiency, although this has not been measured in a high-throughput or rigorous fashion in mammalian synthetic biology systems.As part of our work on ICARUS, we aimed to build and test a catalog of secretion schema for mammalian synthetic biology which identifies the most effective secretion tag and promoter strength for a given size of cargo.

Selecting tag-cargo combinations

Because the ecto-domains of specific cancer antigens can vary in size, we wanted to determine the best secretion tag to use for a wide range of cargo sizes. We selected four proteins ranging from 184 to 1024 amino acids to use as test cargo:

We then identified commonly used secretion tags for mammalian cells (Reference: Commonly used leader peptide sequences for mammalian cells expression, NovoPro) and selected four tags that endogenously signal the secretion of varying-sized proteins, along with a control.

Iterative Design of Secretion Schema

We went through three design cycles to determine how to best construct our secretion catalog. In the end, we found the most success with the cargo-swap protocol, a method we developed and used to successfully build and test secretion of our four different-sized cargos in combination with the five unique secretion tags.

1. Site-directed mutagenesis

Typically, in order to combine gene fragments, it is neccesary to clone each fragment separately then attach them using Gibson assembly. However, because the secretion tags we wanted to attach to the cargo were small (40-70bp), we first tried to use a technique called site-directed mutagenesis (SDM). SDM allows for the insertion of small gene fragments into double-stranded plasmid DNA via PCR, bypassing the need for Gibson assembly. With SDM, the genetic sequences for the insert is tacked on to the ends of the forward and reverse primers that will be used to copy the backbone. Then, when the primers attach to the backbone during PCR, the insert becomes integrated into the backbone. The end result is numerous copies of the backbone, with the insert added in its proper location.

To construct plasmids via site-directed mutagenesis, we designed and ordered primers that targeted the insertion site and contained the gene for the secretion tag. We used our previously-constructed pcDNA5-sfGFP backbone for these proof-of-concept experiments, exchanging only the secretion tag across the different trials. We ran multiple trials of PCR with the backbone and specific primers, then ran gel electrophoresis to determine if amplification occured. Then we transformed the plasmids into E.coli and let them grow up before isolating the DNA and sending it for sequencing to determine if the secretion tag had been properly inserted.

See "Site-Directed Mutagenesis Protocol" under "Experiments" for further detail.

Because the secretion tags are very short sequences, it is impossible to conclude from gel electrophoresis alone whether or not the tag was properly inserted via PCR. As a result, we had to carry out the entire transformation, culture, and DNA isolation protocol before obtaining sequencing results. Despite several attempts with each secretion tag, upon receiving the sequencing results, only one of the four peptides, HSA, had been properly inserted.

We then successfully transfected the HSA-sfGFP construct into HEK cells and measured secretion of sfGFP, which served as a valuable proof-of-concept (See Results > HSA for further details). However, the overall success rate of site-directed mutagenesis was low for this experiment.

Through our experiments in site-directed mutagenesis, we learned that using small inserts attached to the primers themselves is not always reliable. Colonies were grown, but the plasmids did not contain the insert. Some possible ways to troubleshoot the experiments could be redesigning the primers, increasing the time of the DpnI digest to decrease the likelihood that we transform with an unmodified plasmid, or picking multiple colonies for inoculation into liquid culture to obtain more sets of DNA that could contain the proper insert.

2. Two-fragment Gibson assembly

Because we were unable to insert the secretion tags as part of the primers using site-directed mutagenesis, our next idea was to order short fragments containing only the secretion tags. We planned to run PCR on the secretion tags as well as the cargo-containing backbone pieces, then use Gibson Assembly to combine the backbone and the insert. This involves more steps than site-directed mutagenesis, but would possibly be more reliable since we'd already had experience with Gibson Assembly.

We ordered five short DNA fragments, each containing one of the secretion tags (IFNa, IGK8, CTR, SP, and HA). We planned to insert the tags into the pcDNA5-sfGFP backbone we'd constructed, using sfGFP as our test cargo for these experiments. We multiplied the DNA using PCR, ran gel electrophoresis to confirm that we had fragments of the proper sizes, and then attempted to do Gibson Assembly on the fragments. Again, we had to transform the assembled plasmids into E.coli, plate the cells, inoculate into liquid culture, then extract and purify the DNA before we could obtain sequencing results.

After sending the DNA to get sequenced, we found that none of the Gibson Assembly rounds had been effective. Most of the results we had showed the pcDNA5-sfGFP plasmid unmodified, inicating that the small inserts containing the secretion tags had not been inserted.

From these experiments, we learned that Gibson Assembly with very small fragments is difficult. With an insert of only ~60 base pairs, it is likely that the T5 exonuclease enyzyme used for Gibson Assembly digested the fragments before they could be attached. We needed to find a way to attach the secretion tags to the cargo and backbone that didn't involve Gibson Assembly of such small parts.

3. Cargo-swap protocol

At this point, we had realized that we could not count on being able to insert or attach the small signal peptides into the larger cargo-backbone constructs using any traditional insertion method. As an alternative, we decided to order longer sequences as gBlocks that contained a signal peptide already attached to one of our cargos. This meant that when we performed Gibson Assembly with the pcDNA5 backbone, we would end up with five completed plasmids, each containing a different cargo with a different secretion tag already attached.

Once we had these plasmids complete, it would theoretically be easier to swap out the cargo sequences and leave the secretion tags attached to the backbones. While the secretion tags are only around 20 amino acids, the cargo molecules are much larger, between 184-1024 amino acids. This would mean that it would be far easier to cut out and duplicate these larger genes, then perform Gibson Assembly to attach them into the secretion tag-backbone constructs.

Constructing the entire catalog of tag-cargo permuations involved many rounds of PCR and Gibson Assembly. Each of the five tag-cargo sequences we ordered had to be inserted into the pcDNA5 backbone. Once this was completed, primers were needed to cut out both the cargo and the tag-backbone fragment from each plasmid. This resulted in a full set of each cargo as well as each tag attached to the backbone. Finally, each cargo could be added to the different tag-backbone fragments. Following Gibson Assembly, all plasmids were transformed into E.coli, for culturing, then the DNA was extracted and sequenced.

With this method of swapping out just the cargo from pre-constructed complete plasmids, we finally saw large-scale success in the construction of our secretion catalog.

Gibson Assembly with the larger cargo fragments was far easier than with the small secretion tag fragments. Despite some challenges with the PCR of the original parts, we were able to successfuly build the plasmids for our secretion catalog.

Exploring combined effect of promoter strength and signal peptide type

In this study, we collaborated with Asimov to test the combined effect of promoter strength and signal peptide type on the secretion of proteins using a flow cytometry assay. Commonly used promoters such as CMV (BBa_I712004), CAG (BBa_K2217010), EF1$\alpha$ (BBa_K2520023), and SV40 (BBa_K1722006) were selected for the Asimov flow cytometry scaffold. Additionally, we selected 5 signal peptides previously used to secrete proteins in mammalian systems as our candidates for the antigen signal peptide.

As part of our experimental design, we also included the HA epitope tag as our negative secretion control. This control group serves as a baseline reference, enabling us to normalize the secretion levels of the proteins against those with the HA-tag, and make meaningful conclusions about the impact of the different variables being tested. We assume that HA-tagged proteins will not secrete through normal pathways, but that death and lysis of cells may result in background levels of fluorescence during experiments.

The Asimov scaffold expresses two reporter proteins, mEYFP as the reporter of secretion and TagBFP as the reporter of transfection efficiency. The expression of these two reporters allowed us to normalize the secretion results across different transfection efficiencies and make meaningful conclusions about the secretion efficiency, considering that TagBFP has no tags for secretion and a common MmPgk1 promoter in all constructs. By analyzing the mEYFP median fluorescence intensity (MFI) normalized to the TagBFP MFI, we can compare how signal peptides reduce intracellular mEYFP as a quantitative measure of secretion.

The plasmid DNA was synthesized by GeneScript. The scaffolds containing CAG promoter were not constructed due to synthesis issues (please see our parts page for the full list of tested constructs).

HEK293 Freestyle cells were transfected with 300 ng of DNA into 1 000 000 cells per mL in a 170 µL total culture volume in 96-well plates. Following transfection, the cells were incubated for 48 hours in an incubator at 350 rpm, 37°C, 8% CO$_2$. The cells were then resuspended in 200 µL of PBS and analyzed on the flow cytometer (please see our measurement page for results of this study).

Flow cytometry data analysis indicated that the promoter strength plays a major role in the amount of the protein secreted as indicated by HA-tagged constructs, with EF1⍺ and CMV promoters having the highest abundance. The signal peptide type did influence this metric in a significant manner, as indicated by the significant reduction in intracellular mEYFP for all constructs. Perhaps, the selection of our signal peptides was not broad enough to reveal the most optimal candidate as these appear to have similar YFP/BFP ratios. This insight will aid our promoter and signal peptide selection choices for the future iteration of the antigen secretion construct.